Allelic expression imbalance of PIK3CA mutations is frequent in breast cancer and prognostically significant
Lizelle Correia(University of Algarve), Ana-Teresa Maia(Cancer Research UK), Chong Sun(Canadian Institute for Advanced Research), René Bernards(The Netherlands Cancer Institute), Astrid Bosma(The Netherlands Cancer Institute), Marinella N. Ghezzo(Centre for Health Technology and Services Research), Lorenza Mittempergher(The Netherlands Cancer Institute), Ramiro Magno(Centre for Health Technology and Services Research), Bernardo P. de Almeida(Research Institute of Molecular Pathology), Joana M. Xavier(Centre for Health Technology and Services Research), Carlos Caldas(Université Libre de Bruxelles), Isabel Duarte(Centre for Health Technology and Services Research), Filipa Esteves(Algarve Biomedical Center), Ana Marreiros(Algarve Biomedical Center), Matthew Eldridge(University of Cambridge), Suet‐Feung Chin(University of Cambridge)
Cited by 8
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k